Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3247)
All Articles published online
|
Jun 7, 2012 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shen Y, Yang J, Xu Z, Gu DY, Chen JF. Phosphatase and tensin homolog expression related to cetuximab effects in colorectal cancer patients: A meta-analysis. World J Gastroenterol 2012; 18(21): 2712-2718 [PMID: 22690082 DOI: 10.3748/wjg.v18.i21.2712] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i21/2712.htm |
| Number | Citing Articles |
| 1 |
Antonia R. Sepulveda, Stanley R. Hamilton, Carmen J. Allegra, Wayne Grody, Allison M. Cushman-Vokoun, William K. Funkhouser, Scott E. Kopetz, Christopher Lieu, Noralane M. Lindor, Bruce D. Minsky, Federico A. Monzon, Daniel J. Sargent, Veena M. Singh, Joseph Willis, Jennifer Clark, Carol Colasacco, R. Bryan Rumble, Robyn Temple-Smolkin, Christina B. Ventura, Jan A. Nowak. Molecular Biomarkers for the Evaluation of Colorectal Cancer. The Journal of Molecular Diagnostics 2017; 19(2): 187 doi: 10.1016/j.jmoldx.2016.11.001
|
| 2 |
Khalid El Bairi, Csongor Lengyel, Antonio Marra, Said Afqir. Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing. 2020; : 29 doi: 10.1007/978-3-030-53821-7_2
|
| 3 |
Vishal Das, Jatin Kalita, Mintu Pal. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges. Biomedicine & Pharmacotherapy 2017; 87: 8 doi: 10.1016/j.biopha.2016.12.064
|
| 4 |
Evangelia Razis, George Pentheroudakis, George Rigakos, Mattheos Bobos, George Kouvatseas, Olympia Tzaida, Thomas Makatsoris, Pavlos Papakostas, Maria Bai, Anna Goussia, Epaminontas Samantas, Demetrios Papamichael, Ourania Romanidou, Ioannis Efstratiou, Eleftheria Tsolaki, Amanda Psyrri, Wendy De Roock, Dimitrios Bafaloukos, George Klouvas, Sabine Tejpar, Konstantine T. Kalogeras, Dimitrios Pectasides, George Fountzilas. EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab. Journal of Cancer Research and Clinical Oncology 2014; 140(5): 737 doi: 10.1007/s00432-014-1626-2
|
| 5 |
Timothy L. Cannon, Megan A. Kokon, Sara Shafqat, John F. Deeken. RAS Mutations Beyond KRAS Exon 2: A Review and Discussion of Clinical Trial Data. Current Treatment Options in Oncology 2015; 16(7) doi: 10.1007/s11864-015-0350-8
|
| 6 |
Antonia R. Sepulveda, Stanley R. Hamilton, Carmen J. Allegra, Wayne Grody, Allison M. Cushman-Vokoun, William K. Funkhouser, Scott E. Kopetz, Christopher Lieu, Noralane M. Lindor, Bruce D. Minsky, Federico A. Monzon, Daniel J. Sargent, Veena M. Singh, Joseph Willis, Jennifer Clark, Carol Colasacco, R. Bryan Rumble, Robyn Temple-Smolkin, Christina B. Ventura, Jan A. Nowak. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. Archives of Pathology & Laboratory Medicine 2017; 141(5): 625 doi: 10.5858/arpa.2016-0554-CP
|
| 7 |
Chia Wen Liu, Wen Jen Lin. Using doxorubicin and siRNA-loaded heptapeptide-conjugated nanoparticles to enhance chemosensitization in epidermal growth factor receptor high-expressed breast cancer cells. Journal of Drug Targeting 2013; 21(8): 776 doi: 10.3109/1061186X.2013.811511
|
| 8 |
Antonia R. Sepulveda, Stanley R. Hamilton, Carmen J. Allegra, Wayne Grody, Allison M. Cushman-Vokoun, William K. Funkhouser, Scott E. Kopetz, Christopher Lieu, Noralane M. Lindor, Bruce D. Minsky, Federico A. Monzon, Daniel J. Sargent, Veena M. Singh, Joseph Willis, Jennifer Clark, Carol Colasacco, R. Bryan Rumble, Robyn Temple-Smolkin, Christina B. Ventura, Jan A. Nowak. Molecular Biomarkers for the Evaluation of Colorectal Cancer. American Journal of Clinical Pathology 2017; 147(3): 221 doi: 10.1093/ajcp/aqw209
|
| 9 |
Wen Jen Lin, Li Ting Kao. Cytotoxic enhancement of hexapeptide-conjugated micelles in EGFR high-expressed cancer cells. Expert Opinion on Drug Delivery 2014; 11(10): 1537 doi: 10.1517/17425247.2014.930433
|
| 10 |
Mohammad‐Javad Sanaei, Ayda Baghery Saghchy Khorasani, Atieh Pourbagheri‐Sigaroodi, Shabnam Shahrokh, Mohammad Reza Zali, Davood Bashash. The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles. Journal of Cellular Physiology 2022; 237(3): 1720 doi: 10.1002/jcp.30655
|
| 11 |
Nele Boeckx, Ken Op de Beeck, Vanessa Deschoolmeester, Guy Van Camp, Patrick Pauwels, Marc Peeters. Anti-EGFR Resistance in Colorectal Cancer: Current Knowledge and Future Perspectives. Current Colorectal Cancer Reports 2014; 10(4): 380 doi: 10.1007/s11888-014-0242-5
|
| 12 |
Antonia R. Sepulveda, Stanley R. Hamilton, Carmen J. Allegra, Wayne Grody, Allison M. Cushman-Vokoun, William K. Funkhouser, Scott E. Kopetz, Christopher Lieu, Noralane M. Lindor, Bruce D. Minsky, Federico A. Monzon, Daniel J. Sargent, Veena M. Singh, Joseph Willis, Jennifer Clark, Carol Colasacco, R. Bryan Rumble, Robyn Temple-Smolkin, Christina B. Ventura, Jan A. Nowak. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. Journal of Clinical Oncology 2017; 35(13): 1453 doi: 10.1200/JCO.2016.71.9807
|
| 13 |
Christine Koulis, Raymond Yap, Rebekah Engel, Thierry Jardé, Simon Wilkins, Gemma Solon, Jeremy D. Shapiro, Helen Abud, Paul McMurrick. Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer. Cancers 2020; 12(4): 812 doi: 10.3390/cancers12040812
|
| 14 |
Olorunseun O. Ogunwobi, Fahad Mahmood, Akinfemi Akingboye. Biomarkers in Colorectal Cancer: Current Research and Future Prospects. International Journal of Molecular Sciences 2020; 21(15): 5311 doi: 10.3390/ijms21155311
|
| 15 |
Lillian M. Smyth, Kelsey R. Monson, Komal Jhaveri, Alexander Drilon, Bob T. Li, Wassim Abida, Gopa Iyer, John F. Gerecitano, Mrinal Gounder, James J. Harding, Martin H. Voss, Vicky Makker, Alan L. Ho, Pedram Razavi, Alexia Iasonos, Philip Bialer, Mario E. Lacouture, Jerrold B. Teitcher, Joseph P. Erinjeri, Nora Katabi, Matthew G. Fury, David M. Hyman. A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel. Investigational New Drugs 2017; 35(6): 742 doi: 10.1007/s10637-017-0445-0
|
| 16 |
Zhiqiang Cai, Fuxiang Zhou. A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer. Medicine 2022; 101(46): e31127 doi: 10.1097/MD.0000000000031127
|
| 17 |
Adriana González, Iker Badiola, Asier Fullaondo, Javier Rodríguez, Adrian Odriozola. Advances in Host Genetics and Microbiome in Colorectal Cancer-Related Phenotypes. Advances in Genetics 2024; 112: 411 doi: 10.1016/bs.adgen.2024.08.004
|
| 18 |
Zeinab Safarpour Lima, Mostafa Ghadamzadeh, Farzad Tahmasebi Arashloo, Ghazaleh Amjad, Mohammad Reza Ebadi, Ladan Younesi. Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms. Journal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0725-6
|